Written by Steven Hansen
The U.S. new cases 7-day rolling average are 26.1 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 15.5 % LOWER than the rolling average one week ago. U.S. deaths due to coronavirus are now 8.5 % LOWER than the rolling average one week ago. Today’s posts include:
- U.S. Coronavirus New Cases are 70,188
- U.S. Coronavirus hospitalizations are at 63,398
- U.S. Coronavirus deaths are at 2,459
- U.S. Coronavirus immunizations have been administered to 16.8 % of the population
- The 7-day rolling average rate of growth of the pandemic shows new cases improved, hospitalizations improved, and deaths improved
- Hopefully, these current improving COVID trends will remain in play even with the new strains
- The U.S. lost a whole year of life expectancy – and for Black people, it’s nearly 3 times worse
- Thousands of service members saying no to Covid vaccine
- ‘Somewhere in there, the vaccine got overpromised’: How the COVID-19 vaccination process turned chaotic and confusing
- How will we know we’ve reached herd immunity?
- Genetic mutation inherited from Neanderthals could help protect against severe COVID-19 cases
- Oxford University’s major therapeutics trial goes international
- Surprise Find in COVID-19 Brain Capillaries — Could this contribute to COVID brain fog?
- Pregnant women at higher risk for COVID infection
The recent worsening of the trendlines for new cases is behind us which was attributed to going back to college/university, cooler weather causing more indoor activities, mutation of the virus, fatigue from wearing masks / social distancing, holiday activities, and some loosening of regulations designed to slow the coronavirus spread.
My continuing advice is to continue to wash your hands (especially after using the toilet as COVID first sheds in your stool), putting down the toilet seat (as flushing the toilet releases a plume), wear masks, avoid crowds, and maintain social distancing. No handwashing, mask, or social distancing will guarantee you do not get infected – but it sure as hell lowers the risk in all situations – and the evidence to-date shows a lower severity of COVID-19. In addition, certain activities are believed to carry higher risk – like being inside in air conditioning and removing your mask (such as restaurants, around your children/grandchildren, bars, and gyms). It is all about viral load – and outdoor activities are generally safe if you can maintain social distance. Finally, studies show eating right (making sure you are supporting your immune system) and adequate sleep increase your ability to fight off COVID.
include($_SERVER[‘DOCUMENT_ROOT’].’/pages/coronavirus1.htm’); ?>
Hospitalizations Are The Only Accurate Gauge As Reporting Is Not Affected By Holidays
The 4 day Thanksgiving holiday period put the first wobble in the trends. Over weekends and holidays, the number of new cases and deaths decline. Over weekends, this is not a problem for week-over-week rolling averages as weekends are compared against the previous weekend. But when a holiday falls within a working week, a non-working day is compared to a working day which causes havok in the trends.
However, hospitalizations historically appear to be little affected by weekends or holidays – the daily counts do not vary significantly from day-to-day.
The hospitalization growth rate trend is improving.
For the Thanksgiving and the end of the year holiday period – roughly, it seems each appears to have added around 5 % to the rate of growth of new cases, hospitalizations, and deaths.
Historically, hospitalization growth follows new case growth by one to two weeks.
As an analyst, I use the rate of growth to determine the trend. But, the size of the pandemic is growing in terms of real numbers – and if the rate of growth does not become negative – the pandemic will overwhelm all resources.
The graph below shows the rate of growth relative to the growth a week earlier updated through today [note that negative numbers mean the rolling averages are LOWER than the rolling averages one week ago]. As one can see, the rate of growth for new cases peaked in early December 2020 for Thanksgiving, and early January 2021 for end of year holidays – and the rate of growth is now contracting.
In the scheme of things, new cases decline first, followed by hospitalizations, and then deaths.
It is up to each of our readers to protect themselves and others by washing your hands, wearing a mask, avoiding crowds, and maintaining social distancing.
Will The New Variants Cause The Next Spike?
Maybe and maybe not. It all depends on vaccinations:
- the more people that are vaccinated reduces the pool of people that can be infected. Today we have removed over 16 % of the population from being infected which theoretically should reduce the infection rate by 16 % [it is unstudied whether the vaccines prevent a vaccinated person from being a carrier of the virus even though showing no signs]. If the vaccines are shown to stop transmission, then in theory it would reduce the infection rate by double the percent vaccinated [in this case you prevent your own infection and do not pass it along to another].
- it is also unknown what the effective rate of the current vaccines is against mutations that seem to appear almost daily. As an example, if the effective rate drops to 60%, it means the 16 % reduction in the infection rate discussed above is almost cut in half. The South African and Brazilian variant is somewhat immune to the current vaccines.
- The pandemic should be over immediately if everyone could be vaccinated today. The problem is that every day brings a new mutation (which would not appear if the pandemic was stopped). The longer the immunization process takes – the more ineffective the vaccine will become.
- It is not clear whether the vaccine prevents those vaccinated from spreading the virus. It seems to be well documented that it normally stops the virus from taking hold and when it does not – the infection is mild.
Coronavirus News You May Have Missed
Surprise Find in COVID-19 Brain Capillaries — Could this contribute to COVID brain fog? – MedPage
Large cell nuclei that appeared to be megakaryocytes were found in cortical capillaries of five people who died with severe COVID-19, neuropathologists reported.
“To further characterize these cells, we performed immunohistochemistry for CD61 and CD42b, markers of platelets and megakaryocytes,” wrote David Nauen, MD, PhD, of Johns Hopkins University in Baltimore, and colleagues, in a JAMA Neurology research letter. “CD61 labels these cells, as does CD42b, confirming their megakaryocyte identity.” The cells were distinct from platelet clusters, which were found in postmortem intravascular precipitates.
This is the first known report of megakaryocytes in brain vessels in COVID-19 or any other disease, Nauen noted.
“These are cells that normally live in the bone marrow,” he said. “They’ve been seen in the lung and other places, but not in brain capillaries,” Nauen told MedPage Today. “How they got there is a mystery.”
This atypical finding is “extremely unanticipated and thought-evoking,” observed Gerald Soff, MD, a hematologist with Memorial Sloan Kettering Cancer Center in New York City, who wasn’t involved with the research.
“It’s well known that COVID-19 is associated with activation of the clotting system, and this is part of the clotting system, although not the part that’s typically targeted with anticoagulants,” Soff said in an interview with MedPage Today. “The clinical impact is to be determined, but it suggests we should be looking more aggressively for circulating megakaryocyte fragments, which may indicate an additional target for intervention.”
Pregnant women at higher risk for COVID infection – USA Today
A recent study found pregnant women in Washington state were infected with COVID-19 at a 70% higher rate than others at similar ages.
Additionally, rates of infection among pregnant women of color were far higher than researchers expected, according to the study published in the American Journal of Obstetrics and Gynecology. The study provides further evidence that pregnancy should be considered a high-risk health condition for COVID-19 vaccine priority, said senior author Dr. Kristina Adams Waldorf, an OB-GYN at the University of Washington School of Medicine.
“Our data indicates that pregnant people did not avoid the pandemic as we hoped that they would, and communities of color bore the greatest burden,” Waldorf said.
Thousands of service members saying no to Covid vaccine – NBC
By the thousands, U.S. service members are refusing or putting off the Covid-19 vaccine as frustrated commanders scramble to knock down internet rumors and find the right pitch that will persuade troops to get the shot.
Some Army units are seeing as few as one-third agree to the vaccine. Military leaders searching for answers believe they have identified one potential convincer: an imminent deployment. Navy sailors on ships heading out to sea last week, for example, were choosing to take the shot at rates exceeding 80 percent to 90 percent.
Air Force Maj. Gen. Jeff Taliaferro, vice director of operations for the Joint Staff, told Congress on Wednesday that “very early data” suggests that just up to two-thirds of the service members offered the vaccine have accepted.
Pfizer says South African variant could significantly reduce vaccine protection – CNBC
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer/BioNTech vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.
The study found the vaccine was still able to neutralize the virus and there is not yet evidence from trials in people that the variant reduces vaccine protection, the companies said.
Still, they are making investments and talking to regulators about developing an updated version of their mRNA vaccine or a booster shot, if needed.
For the study, scientists from the companies and the University of Texas Medical Branch (UTMB) developed an engineered virus that contained the same mutations carried on the spike portion of the highly contagious coronavirus variant first discovered in South Africa, known as B.1.351. The spike, used by the virus to enter human cells, is the primary target of many Covid-19 vaccines.
Researchers tested the engineered virus against blood taken from people who had been given the vaccine, and found a two-thirds reduction in the level of neutralizing antibodies compared with its effect on the most common version of the virus prevalent in U.S. trials.
Their findings were published in the New England Journal of Medicine (NEJM).
Because there is no established benchmark yet to determine what level of antibodies are needed to protect against the virus, it is unclear whether that two-thirds reduction will render the vaccine ineffective against the variant spreading around the world.
However, UTMB professor and study co-author Pei-Yong Shi said he believes the Pfizer vaccine will likely be protective against the variant.
“We don’t know what the minimum neutralizing number is. We don’t have that cutoff line,” he said, adding that he suspects the immune response observed is likely to be significantly above where it needs to be to provide protection.
That is because in clinical trials, both the Pfizer/BioNTech vaccine and a similar shot from Moderna Inc conferred some protection after a single dose with an antibody response lower than the reduced levels caused by the South African variant in the laboratory study.
Even if the concerning variant significantly reduces effectiveness, the vaccine should still help protect against severe disease and death, he noted. Health experts have said that is the most important factor in keeping stretched healthcare systems from becoming overwhelmed.
More work is needed to understand whether the vaccine works against the South African variant, Shi said, including clinical trials and the development of correlates of protection – the benchmarks to determine what antibody levels are protective.
[editor’s note: also read Studies show Pfizer, Moderna vaccines could have reduced protection against South Africa variant]
If you think the COVID-19 vaccine rollout seems chaotic and incomprehensible, that the numbers don’t add up and allocations don’t make sense, you’re not alone.
Even people who study this for a living are at a loss.
“None of us know what’s going on,” said Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security.
He has been trying to understand how figures from the Centers for Disease Control and Prevention, the White House and the states fit together, but he can’t.
“I don’t understand why there’s not more transparency,” he said. “They could easily hold a webinar every day to go through the numbers – this is how many boxes we shipped, this is how many boxes are coming next week. The more they don’t do that, the more acrimony that’s created between states and the federal government.”
Overall the trends are positive, but the pace will need to intensify significantly to meet deadlines the White House announced this week.
Since Jan. 25, COVID-19 vaccine distribution from the federal government has increased 57%. As of this week, it’s up to 13.5 million doses shipped a week.
“We are on track to have enough vaccine supply for 300 million Americans by the end of July,” Jeff Zients, White House COVID-19 response coordinator, said in a task force briefing Wednesday.
To get the scheduled two doses of the authorized vaccines to 300 million people, distribution from the federal government will need to ramp up by about one-third. At the current level, it would take until September.
The U.S. lost a whole year of life expectancy – and for Black people, it’s nearly 3 times worse – Yahoo
A study published Thursday found life expectancy in the United States dropped to its lowest level in 15 years, and even lower for Black Americans and Latinos, during the first half of the coronavirus pandemic.
Data through June 2020 shows life expectancy at birth for the total U.S. population fell from 2019 by a year to 77.8 years, the lowest since 2006, according to researchers at the Centers for Disease Control and Prevention’s National Center for Health Statistics.
Life expectancy for Black populations declined the most from 2019 – by 2.7 years, to 72 years – its lowest level since 2001. Latinos experienced the second-biggest decline, falling 1.9 years since 2019 to a life expectancy of 79.9 years, lower than when it was first recorded in 2006.
The disparities highlighted in the study add to the mounting evidence of COVID-19’s disproportional effect on Blacks and Latinos, health experts say.
“It was disturbing to see that gains that have been made for the Black community and decreasing the gap between life expectancy for African Americans and (white) Americans over the past six years had come to a halt,” said Dr. Leon McDougle, president of the National Medical Association.
ZDoggMD talks first-hand on the second vax dose and why it’s a doozy – MedPage
How will we know we’ve reached herd immunity? – AP
Health officials around the world are racing to vaccinate enough people to stop the spread of COVID-19, but what qualifies as “enough” is still an open question.
The goal is to get to “herd immunity,” which is when enough people have immunity, either from vaccination or a past infection, to stop uncontrolled spread.
Herd immunity doesn’t make any one person immune, and outbreaks can still flare up. It means that a virus is no longer easily jumping from person to person, helping to protect those who are still vulnerable to catching it.
Nobody knows for sure what the herd immunity threshold is for the coronavirus, though many experts say it’s 70% or higher. And the emergence of variants is further complicating the picture.
… Proof that we’re nearing herd immunity would be a “disruption in the chain of transmission,” said Ashley St. John, who studies immune systems at Duke-NUS Medical School at Singapore.
But don’t wait for any big declaration that we’ve reached that milestone.
To determine whether to relax restrictions, health officials will be watching infection and hospitalization trends as vaccinations roll out. And those decisions are likely to begin long before the ideal herd immunity threshold is reached, though they will be gradual and vary by region.
In India, for instance, scientists believe that more people will need to be protected in densely populated cities, where the virus spreads faster, than in its vast countryside.
India plans to look for antibodies in people nationally to figure out what percentage of its nearly 1.4 billion people have already been infected, said Dr. Jayaprakash Muliyil, who is advising the government on virus surveillance.
… Global herd immunity is ideal but unlikely.
Rich nations have reserved most vaccines that will be manufactured this year. In the U.S., for example, officials have said enough people could be vaccinated by fall to start to return to normal.
But many poorer countries will likely have to wait longer. This is why the World Health Organization has warned that global herd immunity is unlikely to be achieved this year.
Differences in vaccination levels among countries are also why many experts believe the virus will never be completely stamped out.
Genetic mutation inherited from Neanderthals could help protect against severe COVID-19 cases – The Hill
Researchers have discovered a possible genetic link between Neanderthal DNA and a lower risk of developing a severe case of the coronavirus.
A new study, conducted by Hugo Zeberg and Svante Pääbo at the Max Planck Institute for Evolutionary Anthropology in Germany, followed up on recent research that suggested Neanderthal DNA was actually linked to higher risk of severe illness.
They found that a certain haplogroup, a population that shares common DNA, was roughly 22 percent less likely to develop a severe case of COVID-19. The common DNA is believed to have been inherited from Neanderthals.
The haplogroup is common in populations outside of Africa, the study notes, as Neanderthal evolved off the continent.
The Neanderthal DNA believed to protect against illness was found on the 12th chromosome, while the DNA discovered in a previous study that researchers theorized increased the chances of severe illness was found on the third chromosome.
Oxford University’s major therapeutics trial goes international – CNN
A major UK trial of potential Covid-19 treatments has started to enroll patients in other countries in the hope of speeding up results, Oxford University said on Thursday.
The RECOVERY trial — billed by the British government at its launch as the world’s largest randomized clinical trial — looks at whether existing drugs can be used to treat the virus. It has enrolled more than 36,000 hospital patients in the UK since March 2020 and is now expanding to countries including Indonesia and Nepal.
Peter Horby, professor of Emerging Infectious Diseases and Global Health at Oxford, said he hoped that expanding the trial internationally would enable researchers to assess potential treatments more quickly.
It is particularly important to find readily and affordable treatments for COVID-19 that can be used worldwide,” Horby added. “RECOVERY International will help us to identify effective treatments that can be used in less well-resourced settings.”The trial has tested a number of drugs to determine which work against Covid-19 and which don’t. Last year, its researchers found that the cheap steroid dexamethasone reduced the risk of death for the sickest Covid-19 patients – but that the anti-malarial drug hydroxychloroquine was of no benefit.
Last week, it released preliminary results showing that the rheumatoid arthritis drug tocilizumab could also save the lives of patients hospitalized with severe Covid-19. The results were shared in a preprint, but have not yet been peer-reviewed or published in a medical journal.
In Indonesia and Nepal, the trial will initially focus on aspirin and colchicine, a drug for gout.
The following are foreign headlines with hyperlinks to the posts
A look at tensions between mainstream society in Israel and ultra-Orthodox Jews violating antivirus protocols.
Japan belatedly jumps on the vaccination bandwagon in hopes of making the Olympics in July a reality.
Vatican says workers refusing vaccines may be fired
100M workers in eight nations may need to change occupations by 2030 due to COVID-19: McKinsey
Low SARS-CoV-2 Prevalence, Transmission Risk in French Daycare Centers
Hong Kong approves a Chinese vaccine with disappointing trial results.
Northern Ireland extends lockdown until April 1
“Strong and compelling” evidence vaccines are reducing deaths in Scotland, first minister says
Saudi Arabia approves AstraZeneca vaccine
As the WHO probed the pandemic’s origins, China pushed a conspiracy about the US
The following additional national and state headlines with hyperlinks to the posts
NIAID Director Anthony Fauci, MD, told “CBS This Morning” that having every single teacher be vaccinated before schools reopen is a “non-workable situation.”
Feds seize more than 10 million counterfeit N95 masks in recent weeks.
Scientists urge the Biden administration to mandate safety measures against airborne transmission of SARS-CoV-2 in workplaces.
Pennsylvania officials said up to 120,000 second-dose vaccine appointments are in jeopardy after the doses were mistakenly used as first doses.
Now a federal case: the FBI and Justice Department are investigating New York Gov. Andrew Cuomo’s (D) COVID task force for its handling of nursing homes during the pandemic.
Researchers are starting a study on remdesivir use in pregnant women in the U.S.
Florida Gov. Ron DeSantis (R) threatened to pull all vaccines from one county in response to allegations of political favoritism in vaccine distribution.
Actress Gwyneth Paltrow claims to be a COVID-19 long-hauler — as part of a sales pitch for supplements sold by her wellness company Goop.
How billions in pandemic aid was swindled by con artists and crime syndicates
States that imposed lockdown have more COVID-19 deaths per million compared to no-lockdown states
Majority of employers hit with fines over COVID-19 safety haven’t paid: report
Walmart announces raises for 425,000 associates
UK Variant Not Causing Worse Illness in Children
N.Y. legislators are moving to strip Cuomo of his pandemic powers.
White House Chief Medical Advisor Dr. Anthony Fauci said the winter storm and power outages across Texas are a significant problem for Covid-19 vaccine distribution.
The Centers for Disease Control and Prevention’s long-awaited guidance on how to safely reopen schools during the pandemic could end up keeping kids out of the classroom longer than necessary
President Joe Biden‘s prediction that the United States could return to some semblance of normalcy by Christmas is “a reasonable answer
More than 15 million people in the U.S. have received both shots of a two-dose Covid vaccine, according to data from the Centers for Disease Control and Prevention.
Food and packaging highly unlikely to spread Covid-19, US agencies say in reminder
Workers use PPE if employers give it to them, CDC study finds
New standards will take the guesswork out of choosing the most effective face masks
NBA sees an increase in players testing positive for Covid-19
Today’s Posts On Econintersect Showing Impact Of The Pandemic With Hyperlinks
13 February 2021 New York Fed Weekly Economic Index (WEI): Index Modest Decline Continues
January 2021 Residential Building Growth Mixed
January 2021 Import Year-over-Year Inflation Now +0.9%
February 2021 Philly Fed Manufacturing Survey Index Marginally Declined
13 February 2021 Initial Unemployment Claims Rolling Average Improves
Documentary Of The Week: China’s COVID Secrets
Warning to Readers
The amount of politically biased articles on the internet continues to increase. And studies and opinions of the experts continue to contradict other studies and expert opinions. Honestly, it is difficult to believe anything anymore.
I assemble this coronavirus update daily – sifting through the posts on the internet. I try to avoid politically slanted posts (mostly from CNN, New York Times, and the Washington Post) and can usually find unslanted posts on that subject from other sources on the internet. I wait to publish posts on subjects that I cannot validate across several sources. But after all this extra work, I do not know if I have conveyed the REAL facts. It is my job to provide information so that you have the facts necessary – and then it is up to readers to draw conclusions.
Analyst Opinion of Coronavirus Data
There are several takeaways that need to be understood when viewing coronavirus statistical data:
- The global counts are suspect for a variety of reasons including political. Even the U.S. count has issues as it is possible that as much as half the population has had coronavirus and was asymptomatic. It would be a far better metric using a random sampling of the population weekly. In short, we do not understand the size of the error in the tracking numbers.
- Just because some of the methodology used in aggregating the data in the U.S. is flawed – as long as the flaw is uniformly applied – you establish a baseline. This is why it is dangerous to compare two countries as they likely use different methodologies to determine who has (and who died) from coronavirus.
- COVID-19 and the flu are different but can have similar symptoms. For sure, COVID-19 so far is much more deadly than the flu. [click here to compare symptoms]
- From an industrial engineering point of view, one can argue that it is best to flatten the curve only to the point that the health care system is barely able to cope. This solution only works if-and-only-if one can catch this coronavirus once and develops immunity. In the case of COVID-19, herd immunity may need to be in the 80% to 85% range. WHO warns that few have developed antibodies to COVID-19 when recovering from COVID-19. Herd immunity does not look like an option without immunization although there is now a discussion of whether T-Cells play a part in immunity [which means one might have immunity without antibodies]
- Older population countries will have a significantly higher death rate as there is relatively few hospitalizations and deaths in younger age groups..
- There are at least 8 strains of the coronavirus. New York may have a deadlier strain imported from Europe, compared to less deadly viruses elsewhere in the United States.
- Each publication uses different cutoff times for its coronavirus statistics. Our data uses 11:00 am London time. Also, there is an unexplained variation in the total numbers both globally and in the U.S.
What we do or do not know about the coronavirus [actually there is little scientifically proven information]. Most of our knowledge is anecdotal, from studies with limited subjects, or from studies without peer review.
- How many people have been infected as many do not show symptoms?
- Masks do work. Unfortunately, early in the pandemic, many health experts — in the U.S. and around the world — decided that the public could not be trusted to hear the truth about masks. Instead, the experts spread a misleading message, discouraging the use of masks.
- Current thinking is that we develop 5 months of immunity from further COVID infection.
- The Moderna and Pfizer vaccines have an effectiveness rate of about 95 percent after two doses. That is on par with the vaccines for chickenpox and measles. The 95 percent number understates the effectivenessas it counts anyone who came down with a mild case of Covid-19 as a failure. But turning Covid into a typical flu — as the vaccines evidently did for most of the remaining 5 percent — is actually a success. Of the 32,000 people who received the Moderna or Pfizer vaccine in a research trial, only one contracted a severe Covid case.
- To what degree do people who never develop symptoms contribute to transmission? Research early in the pandemic suggested that the rate of asymptomatic infections could be as high as 81%. But a meta-analysis, which included 13 studies involving 21,708 people, calculated the rate of asymptomatic presentation to be 17%.
- The accuracy of rapid testing is questioned – and the more accurate test results are not being given in a timely manner.
- Can children widely spread coronavirus? [current thinking is that they are a minor source of the pandemic spread]
- Why have some places avoided big coronavirus outbreaks – and others hit hard?
- Air conditioning contributes to the pandemic spread.
- It appears that there is increased risk of infection and mortality for those living in larger occupancy households.
- Male patients have almost three times the odds of requiring intensive treatment unit (ITU) admission compared to females.
- Outdoor activities seem to be a lower risk than indoor activities.
- Will other medical treatments for Covid-19 ease symptoms and reduce deaths? So far only remdesivir, Bamlanivimab,
and Regeneron) are approved for treatment. What drugs work? Arthritis drugs tocilizumab and sarilumab could cut relative risk of death of those in intensive care by 24%
- A current scientific understanding of the way the coronavirus works can be found [here].
There is now a vaccine available – the questions remain:
- how effective it will be in the general population,
- will there be any permanent side effects that will appear months from now,
- how long immunity will last [we can currently say we do not know if it will last more than 4 months],
- there is no evidence the vaccine will block transmission
Heavy breakouts of coronavirus have hit farmworkers. Farmworkers are essential to the food supply. They cannot shelter at home. Consider:
- they have high rates of respiratory disease [occupational hazard]
- they travel on crowded buses chartered by their employers
- few have health insurance
- they cannot social distance and live two to four to a room – and they eat together
- some reports say half are undocumented
- they are low paid and cannot afford not to work – so they will go to work sick
- they do not have access to sanitation when working
- a coronavirus outbreak among farmworkers can potentially shutter entire farm
The bottom line is that COVID-19 so far has been shown to be much more deadly than the data on the flu. Using CDC data, the flu has a mortality rate between 0.06 % and 0.11 % Vs. the coronavirus which to date has a mortality rate of 4 % [the 4% is the average of overall statistics – however in the last few months it has been hovering around 1.0%] – which makes it between 10 and 80 times more deadly. The reason for ranges:
Because influenza surveillance does not capture all cases of flu that occur in the U.S., CDC provides these estimated ranges to better reflect the larger burden of influenza.
There will be a commission set up after this pandemic ends to find fault [it is easy to find fault when a once-in-a-lifetime event occurs] and to produce recommendations for the next time a pandemic happens. Those that hate President Trump will conclude the virus is his fault.
Resources:
- Get the latest public health information from CDC: https://www.coronavirus.gov .
- Get the latest research from NIH: https://www.nih.gov/coronavirus.
- Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/.
- List of studies: https://icite.od.nih.gov/covid19/search/#search:searchId=5ee124ed70bb967c49672dad
include(“/home/aleta/public_html/files/ad_openx.htm”); ?>